Below are the three companies in the Biotechnology industry with the highest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.
Biogen Idec (NASDAQ:BIIB) is highest with sales per share of $22.65. Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products addresses diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.
Over the past year, Biogen Idec has traded in a range of $109.05 to $157.18 and is now at $151.34, 39% above that low. In the last five trading sessions, the 50-day moving average (MA) has remained constant while the 200-day MA has risen 0.2%.
Following is Amgen (NASDAQ:AMGN) with sales per share of $21.14.
Finishing up the top three is United Therapeutics (NASDAQ:UTHR), with sales per share of $16.38.